AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2021
Dec 10, 2021
33153_dirs_2021-12-10_3c5c2af4-a9d3-4bf3-afef-cc96c727a922.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2021-12-10
Reporting Person: Sakys John (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-10 | Common Stock | M | 158 | $89.7 | Acquired | 7672 | Direct |
| 2021-12-10 | Common Stock | M | 1600 | $97.78 | Acquired | 9272 | Direct |
| 2021-12-10 | Common Stock | S | 1758 | $324.74 | Disposed | 7514 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-10 | Incentive Stock Option | $89.7 | X | 158 | Disposed | 2022-04-01 | Common Stock (158) | Direct |
| 2021-12-10 | Non Qualified Stock Option | $97.78 | X | 1600 | Disposed | 2022-04-01 | Common Stock (1600) | Direct |
Footnotes
F1: 1/7 exercisable on each anniversary date of the 04/01/2014 grant date
F2: 1/5 exercisable on each anniversary date of the 04-01-2016 grant date
F3: Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on March 1, 2021
More from MESA LABORATORIES INC /CO/
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6
Regulatory Filings
2025
Nov 6